GlobeNewsWire
23 Apr 2026, 20:05 UTC · 30w ago
Trevi Therapeutics to Participate in Upcoming May Events
Impact · against what's priced in
Trevi Therapeutics has a high-catalyst month ahead in May, featuring an Investor Day and data presentations at the ATS conference. While conference appearances are routine, the presentation of clinical data highlights typically provides the primary volatility driver for clinical-stage biotechs.
- TRVI+0.30
No priced-in read yet
- In context
The scheduling of data highlights from ATS 2026 presentations on May 18 serves as a primary catalyst for potential price movement based on clinical results.
Read from the article alone





